Scientex’s FY14 core earnings of MYR146.30m met our expectations. We raise our FV to MYR8.64 (from MYR7.19) as we peg a revised CY15 P/E of 15x (from 12x) to the packaging division, which better reflects growth prospects. We maintain BUY as our new FV implies a 24.3% upside. Management unveiled its expansion strategy to quadruple consumer packaging capacity to 120,000 tonnes come 2017. This could propel earnings growth in the foreseeable future.
Largely in line. Scientex’s FY14 revenue of MYR1.59bn closed higher by 29.4% y-o-y, driven by both its packaging arm (+29.8% y-o-y) as well as its property development segment (+28.4% y-o-y). EBIT, meanwhile,grew by a smaller 17.9% y-o-y to MYR181.40m due to: i) higherdepreciation in tandem with its capacity expansion, and ii) a marginal uptick in opex. All in, FY14 core earnings of MYR146.30m were in line with expectations, at 103.3% and 102.1% of consensus and our full-year estimates respectively. 4QFY14 numbers were generally higher y-o-y on better showing from both its core divisions.
Declares DPS of 13.0 sen. Management declared a final DPS of 13.0 sen, bringing its FY14 DPS to 21.0 sen. This translates into a decent payout ratio of 31.3%. Although capital investment stands at over MYR240m over the next two years, management reiterated its dividend commitment of a minimum 30% payout.
Forecasts and risks. Taking into account the group’s proposed expansion plans for its consumer packaging arm, we upgrade our FY15F-16F EPS estimates by 2-6%. Key risks include a potential slowdown in property sales amidst rising costs of living and potential fluctuations in prices of resin, which is its core production input.
Maintain BUY. We came out of the briefing feeling positive on its medium-term earnings prospects, leveraging on its expansion strategy to quadruple its consumer packaging capacity by 2017. We also see positives in its partnership with Japan’s Futamura Chemical to help expand its biaxially oriented polypropylene (BOPP) film presence. As such, we maintain our BUY call. We also increase our SOP-based FV to MYR8.64 (from MYR7.19) following our earnings revision, and as we peg a revised CY15 P/E of 15x (from 12x) to its packaging division, which better reflects its earnings growth prospects at a CAGR of 20% over the next three years.
Briefing Highlights
Details on partnership. We attended the official signing ceremony for the equity participation in Scientex’s consumer packaging arm Scientex Great Wall SB (SGW)by Futamura Chemical Company Ltd (FutChem) held at Shangri-La Hotel, KL. Based on the signed agreement, FutChem will inject MYR40m capital into SGW. In return, the Japanese group will hold a 5% stake in SGW. On a side note, FutChem is entitled to purchase up to 20% stake in SGW over next five years , with pricing to be determined later on.
New BOPP film plant. As part of the agreement, SGW will build a new BOPP film manufacturing plant in Pulau Indah, Port Klang at an estimated capital outlay of MYR170m. The plant will have an annual production capacity of 60,000 tonnes of BOPP films upon completion by end-2016. Upon commencement of the plant, FutChem will be allocated 30% of the production capacity for sale and distribution in Japan. The remaining 70% will be marketed in Malaysia and other South-East Asiancountries by Scientex.
Penetrating into new segment. In addition, SGW has announced its intention topenetrate into the cast polypropylene (CPP) film, with an initial production capacity of 12,000 tonnes. This new setup will cost an estimated MYR50m and we expect full commercial production to commence by 4QCY15.
Consumer packaging to propel growth. With i) the proposed expansion of BOPP film, ii) the setting up of its CPP division, and iii) the ongoing expansion under its polyethylene (PE) film, which is set to be completed by Feb 2015, Scientex’s annual production capacity under its consumer packaging segment will increase to 120,000 tonnes come 2017 from 30,000 tonnes currently. Based on our estimates, this will bump up its segmental revenue contribution to over MYR1bn by FY18F from MYR295.1m in FY14.
Capex allocation of MYR240m. In a nutshell, its proposed expansion plans would require capital investment of over MYR240m over the next two years. We believe funding should not be an issue given: i) its relatively manageable net gearing level of 0.36x currently, ii) annual operating cash flow of over MYR200m per year, and iii) an additional MYR40m cash inflow from FutChem’s subscription of 5% stake in SGW.
Continues to focus on affordable homes. Moving onto its property segment, Scientex booked in new property sales of MYR470m in FY14 vis-à-vis total new launches of MYR590m during the year. Management guided that the majority of the new sales consists of affordable residential properties in Pasir Gudang, Senai, and Kulai in Johor. Unbilled sales amounted to MYR537.4m as of end-July. This, in our view, will likely last the company over a year, given that its FY14 recognised revenue under its property arm registered MYR398.3m. Management is looking at new launches with GDV of MYR550m per year for FY15 and FY16. Its existing landbank now stands at 896 acres with outstanding GDV of over MYR4.3bn.
Embarking on next phase of growth. Overall, we came out of the briefing feeling positive on the group’s medium-term prospects. On its manufacturing division, we find positives in management embarking on the next phase of growth to expand its presence within the relatively better-yielding consumer packaging segment. Although we see minority leakages via FutChem’s 5% stake (or as much as 20% should FutChem fully subscribes for its entitlement) in SGW, having the Japanese group onboard would help to shorten the learning curve given that Scientex is relatively new to the consumer packaging industry. Moreover, FutChem’s acquisition of a 5% stake at MYR40m values SGW at MYR800m in entirety. Based on our estimates, this implies FY14 P/E of over 40x or forward P/E of 11x-12x, which we deem fair, upon completion of all the proposed expansion. On the other hand, we see a relatively stable income stream from its property development arm as the group continues to focus on affordable housing projects over the near term , in view of the cautious sentiment in the premium home market.
Source: RHB
Chart | Stock Name | Last | Change | Volume |
---|
Created by kiasutrader | Jun 14, 2016
Created by kiasutrader | May 05, 2016